Chronic Pain Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

What industry-specific factors are fueling the growth of the chronic pain market?
The chronic pain market is predicted to expand driven by the rise in the number of chronic pain sufferers. Chronic pain sufferers are those who experience persistent or protracted pain that outlasts the typical healing period or continues for a longer duration, usually more than three months. The high incidence of chronic pain sufferers fuels the expansion of the chronic pain market, as the escalating demand for efficacious pain management solutions, including pharmaceuticals and medical devices, fosters innovation and progress in the field. For instance, as per the Australian Institute of Health and Welfare in June 2024, a government agency based in Australia, an approximated 4.0 million Australians (16% of the population) were plagued with back problems in 2022. By 2023, back problems had advanced to the third principal cause of disease strain, accounting for 4.3% of the country's overall disease strain. Furthermore, a report published by the Institute for Health Metrics and Evaluation in February 2024, a public health agency and research institute based in the US opines that global neck pain cases are predicted to touch the 269 million mark by 2050 (with a potential range from 219 to 322 million). This signifies a 32.5% rise (between 23.9% and 42.3%) in comparison to 2020. Consequently, the rise in chronic pain sufferers is propelling the growth of the chronic pain market.

Get Your Chronic Pain Market Report Here:
https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

What Is the projected market size and growth rate for the chronic pain market?
In recent years, the market size for chronic pain has seen substantial growth. The market, valued at $78.79 billion in 2024, is expected to reach $84.96 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.8%. Factors contributing to this growth during the historical period include trauma and injuries, surgical methods, inflammatory ailments, nerve injuries and neuropathy, and an absence of efficient treatments.

In the coming years, the market size of chronic pain is predicted to experience substantial growth. Projections show it increasing to a size of $117.74 billion in 2029 with a compound annual growth rate (CAGR) of 8.5%. The predicted growth during this period could be linked to factors such as an aging populace, the growth of telemedicine, increased public health consciousness, advancements in genetic research and precision medicine, and psychosocial stressors. Notable trends projected for this period include the incorporation of wearable devices, the emergence of pain education and support groups, a holistic approach to pain management, a shift towards non-opioid pain management, and the application of regenerative medicine in pain treatment.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

What new trends are reshaping the chronic pain market and its opportunities?
One significant trend gaining traction in the chronic pain market is the rise of alternative pain management techniques. Firms in the chronic pain sector are concentrating on the creation of new, portable, and easy-to-use nerve stimulation devices. These devices utilise electric impulses to activate nerves and lessen pain, offering a non-invasive option for handling pain and strengthening their market standing. For example, in December 2022, Abbott Laboratories, an American healthcare firm adept in diagnostics, medical equipment, nutrition, and branded generic drugs, introduced a cutting-edge spinal cord stimulation (SCS) system known as Eterna. Currently, it is the smallest implantable, rechargeable device in the chronic pain treatment market. Eterna SCS system incorporates Abbott's proprietary low-dose BurstDR stimulation, which is the only waveform technology backed by in-depth clinical evidence (1A evidence), showing 23% more reduction in pain than traditional waveform technology methods.

What major market segments define the scope and growth of the chronic pain market?
The chronic pain market covered in this report is segmented -

1) By Product: Drug, Devices
2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications
3) By End User: Hospitals, Clinics, Research Organization

Subsegments:
1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids
2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11970

Which region dominates the chronic pain market?
North America was the largest region in the chronic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the chronic pain industry growth?
Major companies operating in the chronic pain market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

What Is Covered In The Chronic Pain Global Market Report?

• Market Size Forecast: Examine the chronic pain market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the chronic pain market for a structured understanding.
• Key Players Overview: Analyze major players in the chronic pain market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the chronic pain market.
• Segment Contributions: Evaluate how different segments drive overall growth in the chronic pain market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the chronic pain market.
• Industry Challenges: Identify potential risks and obstacles affecting the chronic pain market.
• Competitive Landscape: Review strategic developments in the chronic pain market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.